Skip to main content
. 2018 Jun 29;92(14):e00432-18. doi: 10.1128/JVI.00432-18

TABLE 1.

Antibodies and stylet immunolabeling resultsa

Antibody ID Peptide ID AA positions in proteins Peptide sequence Specificity Labeling Accessibility
Anti-1-01 1-01 32–46 ILVQDSAPSADGSLK Stylin-01 + PAc
Anti-1-05 1-05 21–35 PAGQSPESRAVILVQ Stylin-01 + Em
Anti-1-06 1-06 38–52 APSADGSLKNNFQTD Stylin-01 + PAc
Anti-1-07 1-07 32–46 SQEQEVNFDGNFKNK Stylin-02 + PAc
Anti-1-08 1-08 48–62 NFQTDNGIKQEEVRY Stylin-01 NA
Anti-1-09 1-09 59–73 EVRYLKAGPEGPVSV Stylin-01 NA
Anti-1-10 1-10 92–106 YVADENGYQPYGAHL Stylin-01 + Em
Anti-1-11 1-11 121–135 RYLASLPSTPEPKYQ Stylin-01/02 + Ac
Anti-1-13b 1-13 108–122 TPPPIPAEIQESLRY Stylin-01/02 + Em
106–120 LPTPPPIPAEIQESL
a

ID, identifier; AA, amino acid; Ac, epitope exposed at the surface and directly accessible; PAc, epitope poorly accessible (labeling either weak or visible as dots without chitinase treatment); Em, epitope embedded, not accessible at the surface of the stylets (labeling visible only after chitinase digestion); NA, not applicable, because of the total lack of labeling regardless of the treatment. +, labeling observed at the tip of maxillary stylets; −, no labeling detected regardless of the tested conditions.

b

Due to poor immunogenicity prediction, two partially overlapping peptides were used for immunization.